BernardAFischerMD
Psychiatry • Baltimore, MDAssistant Professor, Psychiatry, University of Maryland School of Medicine
Are you Dr. Fischer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 58 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
701 W Pratt St
3rd. Flr
Baltimore, MD 21201Phone+1 410-328-2539
Summary
- Dr. Bernard Fischer, MD is a board certified psychiatrist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and is an Assistant Professor at University of Maryland School of Medicine.
Education & Training
University of Maryland/Sheppard PrattResidency, Psychiatry, 2002 - 2006
Virginia Commonwealth University School of MedicineClass of 2002
Certifications & Licensure
MD State Medical License 2004 - 2026- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Biomarker Study of Acamprosate in Schizophrenia Start of enrollment: 2008 Jun 01
- Risk Perception in Drug-Dependent Adults With and Without Schizophrenia Start of enrollment: 2009 Aug 18
- Topiramate for Alcohol Use in Posttraumatic Stress Disorder Start of enrollment: 2012 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 591 citationsThe Brief Negative Symptom Scale: Psychometric PropertiesBrian Kirkpatrick, Gregory P. Strauss, Linh Nguyen, Bernard A. Fischer, David G. Daniel
Schizophrenia Bulletin. 2011-03-01 - 150 citationsNext-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.Gregory P. Strauss, William R. Keller, Robert W. Buchanan, James M. Gold, Bernard A. Fischer
Schizophrenia Research. 2012-12-01 - 153 citationsFACTOR STRUCTURE OF THE BRIEF NEGATIVE SYMPTOM SCALEGregory P. Strauss, L. Elliot Hong, James M. Gold, Robert W. Buchanan, Robert P. McMahon
Schizophrenia Research. 2012-12-01
Press Mentions
MDMA Is off the Table, so What’s Next for PTSD?October 17th, 2024
ACNP 59th Annual Meeting: Panels, Mini-Panels and Study GroupsDecember 6th, 2020
Professional Memberships
- Member
